Ridhima Sodhi
Datos Biográficos
| ID | 9066925 |
|---|---|
| NOMBRE | Ridhima Sodhi |
| NOMBRES | Ridhima |
| APELLIDO | Sodhi |
| FIRMA | SODHI R |
| AFILIACIONES | Clinton Foundation |
| ORCID | 0000-0003-2401-1065 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2025 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Strengthening TB care pathways
Tuberculosis (TB) continues to be the leading cause of death from infectious diseases, disproportionately affecting populations in low- and middle-income countries, where diagnostic and financial barriers impede timely care. While alternative treatments may offer symptomatic relief, the cornerstone of TB management remains anti-tubercular therapy (ATT) as recommended by the World Health Organization (WHO). Yet, many individuals with TB-like sympt…
Adverse drug reactions in tuberculosis treatment
Adverse drug reactions (ADRs) remain a major barrier to successful tuberculosis (TB) treatment. They undermine adherence, prolong morbidity, and increase the risk of treatment failures and mortality. Yet, evidence on their incidence, duration, and management across diverse patient groups remains limited. We conducted a mixed-methods study to address this gap, using a representative sample of patients from six states in India. Specifically, we com…
Sin obras prominentes en esta página.
Adverse drug reactions in tuberculosis treatment
Adverse drug reactions (ADRs) remain a major barrier to successful tuberculosis (TB) treatment. They undermine adherence, prolong morbidity, and increase the risk of treatment failures and mortality. Yet, evidence on their incidence, duration, and management across diverse patient groups remains limited. We conducted a mixed-methods study to address this gap, using a representative sample of patients from six states in India. Specifically, we com…
Strengthening TB care pathways
Tuberculosis (TB) continues to be the leading cause of death from infectious diseases, disproportionately affecting populations in low- and middle-income countries, where diagnostic and financial barriers impede timely care. While alternative treatments may offer symptomatic relief, the cornerstone of TB management remains anti-tubercular therapy (ATT) as recommended by the World Health Organization (WHO). Yet, many individuals with TB-like sympt…
Tuberculosis Research and Epidemiology (2 obras) · Adverse effect (1 obras) · Antibiotic Use and Resistance (1 obras) · Complementary and Alternative Medicine Studies (1 obras) · Cornerstone (1 obras) · Drug reaction (1 obras) · Drug-Induced Adverse Reactions (1 obras) · Epidemiology (1 obras) · Health care (1 obras) · Intervention (counseling) (1 obras)